SVF Endurance (Cayman) Ltd Reports Disposal of Vir Biotechnology Common Shares
SVF Endurance (Cayman) Ltd has reported the disposal of common shares of Vir Biotechnology Inc., as per a recent SEC Form 4 filing. Other beneficial owners involved include SoftBank Vision Fund (AIV M1) L.P. and SB Investment Advisers (UK) Ltd. The filing was published by Vir Biotechnology Inc. via the SEC's EDGAR system on November 26, 2025.
SVF Endurance (Cayman) Ltd reported a disposal of common shares of Vir Biotechnology Inc., according to a recent SEC Form 4 filing. Other reporting beneficial owners include SoftBank Vision Fund (AIV M1) L.P. and SB Investment Advisers (UK) Ltd, among other reporting beneficial owners. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vir Biotechnology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-025161), on November 26, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
